Adherium (ASX:ADR), a global leader in digital health technologies addressing sub-optimal medication use in chronic disease, has appointed a new Senior Vice President of Business Development and established an operating entity in the UK to serve the European market.
Adherium provides digital health solutions to pharmaceutical, remote patient monitoring and clinical trials companies. Its Smartinhaler platform and products are CE approved and comprise a range of medication sensors which attach to prescription inhalers, along with SmartinhalerLive software, integrating data from the Smartinhalers into a usable form.
Adherium entered a long-term partnership with AstraZeneca in 2015 to supply innovative new devices and sensors to incorporate within global patient support programs for patients with COPD and asthma.
John Tarplee, Senior Vice President Business Development, Europe, will lead market development and partnering for the European market.
In conjunction with Mr Tarplee’s appointment, Adherium has established Adherium Europe , operating from Guildford in the UK.
Mr Tarplee joins Adherium from Danish speciality allergy immunotherapy company ALK-Abello, where he was Senior Vice President Europe North and International Markets Region, responsible for ALK’s commercial operations in those regions as well as commercial leadership for ALK’s geographical expansion strategy.
He previously spent ten years at Sanofi-Aventis as Business Unit Director UK, Senior Director – Sales Force Excellence Europe Region, General Manager Denmark and Sales Manager UK. He has also worked for Abbott Laboratories and in Fisons Pharmaceuticals, having joined the industry in 1986.
Garth Sutherland, CEO of Adherium, said: “Having already established strong ties in Europe, including ongoing clinical trials and our partnership with AstraZeneca, I am delighted to welcome John to the team and to be establishing a formal base of operations on the ground in Europe. Developing our presence in this key market is a milestone for us as we continue to build sales and partnerships worldwide.
“John brings over thirty years’ industry experience, particularly in sales and market expansion. Attracting a senior business development executive of this calibre to expand our footprint and market presence is a strong endorsement of our technology and business model.”
The company said its decisison to establish a European operation and the appointment of a Senior Vice President Business Development, Europe, is part of Adherium's international expansion strategy to better serve global markets. It recently established Adherium North America, based in San Francisco, and appointed James Hattersley as Senior Vice President of Business Development, North America.